Product image of Nolpaza (Pantoprazole) supplied by GNH India

Nolpaza

Active Ingredient:
Pantoprazole
Origin:
EU

Nolpaza (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza, is a proton pump inhibitor presented as a delayed‑release oral tablet for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, erosive oesophagitis and Zollinger‑Ellison syndrome in adults.

GNH India supplies Nolpaza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nolpaza (pantoprazole) is a proton pump inhibitor used to manage conditions driven by excess gastric acid.

  • Gastro‑oesophageal reflux disease (GERD): reduces acid exposure, relieving heartburn and regurgitation.
  • Erosive oesophagitis: promotes healing of acid‑induced esophageal lesions.
  • Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid associated with gastrin‑producing tumors.
  • Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients requiring long‑term NSAID therapy.

How It Works

  • Pantoprazole irreversibly binds to the H+/K+ ATPase (proton pump) located on gastric parietal cells, blocking the final step of acid secretion. By inhibiting this enzyme, it markedly reduces basal and stimulated gastric acid output, allowing the gastric mucosa to heal and decreasing reflux of acidic contents into the esophagus.

Side Effects

Adverse reactions may occur with any medication and should be monitored by a healthcare professional.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Diarrhea: loose stools, often transient.
  • Nausea: feeling of stomach upset.
  • Abdominal pain: discomfort in the upper abdomen.
  • Flatulence: increased gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, difficulty breathing.
  • Clostridioides difficile infection: persistent diarrhea, abdominal cramping.
  • Low magnesium levels: muscle cramps, irregular heartbeat.
  • Liver enzyme elevation: abnormal liver function tests.
  • Bone fracture risk: especially with long‑term use.
  • Acute interstitial nephritis: kidney inflammation presenting with fever and urinary changes.

Precautions & Warnings

Before initiating Nolpaza, consider the following safety measures.

  • Assess renal function: dose adjustment may be needed in severe impairment.
  • Review hepatic status: monitor liver enzymes in patients with liver disease.
  • Evaluate for infections: use cautiously in patients with a history of C. difficile.
  • Monitor electrolytes: especially magnesium during prolonged therapy.
  • Pregnancy and lactation: discuss risks with a healthcare provider as safety data are limited.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Pantoprazole may affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

  • Ketoconazole or itraconazole: reduced antifungal absorption; avoid concurrent use.
  • Atazanavir: markedly decreased antiviral exposure; contraindicated.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible increase in INR; monitor coagulation parameters.
  • Digoxin: slight increase in serum levels; check renal function.
  • Methotrexate (high dose): reduced clearance; monitor for toxicity.
  • Clopidogrel: diminished antiplatelet effect; consider alternative therapy.
  • Iron supplements: decreased iron absorption; separate administration by at least 2 hours.

Frequently Asked Questions

Nolpaza contains pantoprazole, a proton pump inhibitor indicated for the treatment of acid‑related conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis, Zollinger‑Ellison syndrome, and for the prevention of gastric ulcers associated with long‑term NSAID use.

Pantoprazole blocks the H+/K+ ATPase enzyme (the gastric proton pump) in the parietal cells of the stomach. By irreversibly inhibiting this pump, it suppresses the final step of gastric acid secretion, leading to a sustained reduction in stomach acidity.

The prescribed dose of Nolpaza is determined by the treating physician based on the specific indication, severity of disease, and patient characteristics. Typical adult regimens range from 20 mg to 40 mg once daily, but exact dosing should follow the prescriber’s instructions.

Safety data for pantoprazole during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus. Breastfeeding mothers should consult their healthcare provider, as small amounts may be excreted in milk.

To place an order, submit an enquiry on the Nolpaza product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nolpaza (pantoprazole) offers a similar acid‑suppression profile to other PPIs such as omeprazole or esomeprazole, but it has a lower potential for drug‑drug interactions involving CYP2C19 metabolism. Its delayed‑release formulation provides consistent plasma concentrations, making it a preferred option for patients on multiple medications.

Store Nolpaza tablets at ambient temperature below 25 °C, in the original blister pack or container to protect from moisture and light. Keep out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Nolpaza is taken orally as a delayed‑release tablet. It is usually swallowed whole with a glass of water, preferably in the morning before breakfast. The tablet should not be crushed, chewed, or split, as this may compromise the controlled‑release mechanism.

Serious adverse events, though rare, include severe allergic reactions (rash, swelling, breathing difficulty), Clostridioides difficile‑associated diarrhea, low magnesium levels, and acute interstitial nephritis. Patients should seek immediate medical attention if they experience any of these symptoms.

Nolpaza is contraindicated in patients with known hypersensitivity to pantoprazole or any component of the tablet. Caution is advised for individuals with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with a history of C. difficile infection.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT